1. Fabrication and characterisation of CuO nanotubes electrodeposited into aluminium oxide template in ionic liquid. (April 2014) Authors: Liang, Z.; Xie, X.; Jia, J.; Lu, P.; Zhong, L.; Han, L.; Fan, C. Journal: Materials research innovations Issue: Volume 18:Number 3(2014) Page Start: 134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Fabrication and characterisation of CuO nanotubes electrodeposited into aluminium oxide template in ionic liquid. (June 2014) Authors: Liang, Z.; Xie, X.; Jia, J.; Lu, P.; Zhong, L.; Han, L.; Fan, C. Journal: Materials research innovations Issue: Volume 18:Number 3(2014) Page Start: 134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Fabrication and characterisation of CuO nanotubes electrodeposited into aluminium oxide template in ionic liquid. (June 2014) Authors: Liang, Z.; Xie, X.; Jia, J.; Lu, P.; Zhong, L.; Han, L.; Fan, C. Journal: Materials research innovations Issue: Volume 18:Number 3(2014) Page Start: 134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Flux modification for AC-TIG braze welding of aluminium to stainless steel. (August 2014) Authors: He, H.; Yang, C.; Lin, S.; Fan, C.; Chen, Z.; Chen, Z. Journal: Science and technology of welding & joining Issue: Volume 19:Number 6(2014:Aug.) Page Start: 527 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Flux modification for AC-TIG braze welding of aluminium to stainless steel. (June 2014) Authors: He, H.; Yang, C.; Lin, S.; Fan, C.; Chen, Z.; Chen, Z. Journal: Science and technology of welding & joining Issue: Volume 19:Number 6(2014:Aug.) Page Start: 527 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OP0028 Effects of Sarilumab plus MTX on Clinical, Radiographic, and Functional Endpoints in Patients with Moderate-To-Severe Rheumatoid Arthritis: Results of A Phase 3, Randomized, Double-Blind, Placebo-Controlled, International Study. (10th June 2014) Authors: Genovese, M.; Fleischmann, R.M.; Kivitz, A.J.; Rell-Bakalarska, M.; Martincova, R.; Fiore, S.; Rohane, P.; van Hoogstraten, H.; Fan, C.; van Adelsberg, J.; Weinstein, S.; Graham, N.; Stahl, N.; Yancopoulos, G.; Huizinga, T.W.; van der Heijde, D. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SAT0117 Sarilumab, a Subcutaneously-Administered, Fully-Human Monoclonal Antibody Inhibitor of The IL-6 Receptor: Relationship Between Eular Responses and Change from Baseline of Selected Clinical Parameters. (23rd January 2014) Authors: Genovese, M. C.; Fleischmann, R. M.; Fiore, S.; Radin, A.; Fan, C.; Huizinga, T. W. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A620 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. SAT0136 Sarilumab, a Fully Human Mab Against IL-6R Alpha, Subcutaneously-Administered Shows Significant Improvement in Ra Patients as Early as 2 Weeks: A Time to Event Analysis for Acr50 and Eular Good Response. (23rd January 2014) Authors: Fleischmann, R.; Fiore, S.; Fan, C.; Thompson, D. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A627 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗